Response to Letter to the Editor: Palm Oil and Beta-Palmitate in Infant Formula

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10410915" target="_blank" >RIV/00216208:11130/20:10410915 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/20:10410915
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=J~9z99QvBL" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=J~9z99QvBL</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MPG.0000000000002594" target="_blank" >10.1097/MPG.0000000000002594</a>

Result language
angličtina
Original language name
Response to Letter to the Editor: Palm Oil and Beta-Palmitate in Infant Formula
Original language description
We recognize the work of Professor Koo onthe effects of PO on early bone metabolism and note his concerns; however, when we considered other studies identified in our literature review, we do not feel the evidence against its use is conclusive and note that longer term impacts on bone were not apparent. Whilst we do not feel the evidence is sufficient torecommend against use in formula, we do strongly recommendand support the need for further research on the possible long-term health effects of PO/POL/SN-2-palmitate-based infant formulas inwell-designed RCTs.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30209 - Paediatrics

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)